XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
  Autoimmune Diseases
  Immunosupressants
  Monoclonal Antibodies
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Immunology Channel
subscribe to Immunology newsletter

Latest Research : Immunology

   DISCUSS   |   EMAIL   |   PRINT
InterMEM T Cell State Between Naïve and Effector
Apr 8, 2005, 04:35, Reviewed by: Dr.

Previous research has shown that T cells require an encounter with antigen and other signals to undergo clonal expansion and differentiation, but the genetic events that underlie this process are not fully understood.

 
After passing through an intermediary state, naïve T cells concurrently differentiate into memory and effector cells, according to Susan Holmes et al.

Previous research has shown that T cells require an encounter with antigen and other signals to undergo clonal expansion and differentiation, but the genetic events that underlie this process are not fully understood. Holmes et al. used FACSorting to isolate naïve, effector, and memory CD8+ T cells, based on the expression of CD27 and CD45RA, from the peripheral blood of 10 subjects.

The researchers identified 156 genes differentially expressed among the three T cell subsets. By multivariate analysis, they were able to discern an intermediary state between the three cell types, termed InterMEM, which was closer to the memory T cell state than to naïve or effector states. This expression pattern, the researchers argue, supports the parallel differentiation model, in which naïve T cells differentiate into effector and memory cells simultaneously. In addition to CD27 and CD45RA, the authors report other biomarkers able to further discriminate among the three T cell subsets: syntaphilin and IFN-&ggr; receptor 2 for naïve cells; vinculin and granzyme B for effector cells; and T cell receptor-interacting molecule and granzyme K for memory cells.
 

- "Memory T cells have gene expression patterns intermediate between naïve and effector" by Susan Holmes, Michael He, Tong Xu, and Peter P. Lee
 

Read the full text of this article

 
Subscribe to Immunology Newsletter
E-mail Address:

 

The articles in the Proceedings of the National Academy of Sciences report original research by independent authors and do not necessarily represent the view of the National Academies.

Related Immunology News

Pregnant women with lupus are at higher risk for complications
Molecular 'signature' protects cells from viruses
Discovery in the evolution of the immune system absorbing cells
Leeds University study shows eculizumab may be an effective therapy for PNH
Research Reveals Inner Workings of Immune System “Thermostat”
CD23 Protein in Stool Samples may Indicate Food Allergy
Molecular signals triggering maturation of natural killer cells uncovered
New method to analyse the Major Histocompatibility Complex (MHC) of the human genome
Front Line Immune Cells Mature in Four Stages - Study
Caspase-12 gene that shuts down immune system is found in 20% of people of African descent


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us